Journal
APPLIED AND ENVIRONMENTAL MICROBIOLOGY
Volume 73, Issue 22, Pages 7246-7251Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/AEM.01411-07
Keywords
-
Categories
Ask authors/readers for more resources
Engineered microbes are becoming increasingly important as recombinant production platforms. However, the nonfunctionality of membrane-bound cytochrome P450 enzymes precludes the use of industrially relevant prokaryotes such as Escherichia coli for high-level in vivo synthesis of many functional plant-derived compounds. We describe the design of a series of artificial isoflavone synthases that allowed the robust production of plant estrogen pharmaceuticals by E. coli. Through this methodology, a plant P450 construct was assembled to mimic the architecture of a self-sufficient bacterial P450 and contained tailor-made membrane recognition signals. The specific in vivo production catalyzed by one identified chimera was up to 20-fold higher than that achieved by the native enzyme expressed in a eukaryotic host and up to 10-fold higher than production by plants. This novel biological device a strategy for the utilization of laboratory bacteria to robustly manufacture high-value plant P450 products.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available